Transaction · 0001673528-26-000017

Faga Daniel

Faga Daniel, PRES, CEO, reported a transaction classified as grant at First Tracks Biotherapeutics, Inc. involving 193575.000000 shares for an estimated $0.00. Reported holdings after the transaction were 440485.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code APRES, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Filing timeAug 18
Trade dateAug 15, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$43.88
Pre-filing
1mo ago -17.5%1w ago +3.3%1d ago +0.4%
Returns since
7d +3.8%30d -6.2%90d -6.2%180d -6.2%1y -6.2%

TRAX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
TRAX since 2026-08-18Filed 18 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001673528-26-000017
Performance Stock Units
Transaction date
Aug 15, 2026
Filed Aug 18, 2026, 08:05 PM · 3d delay
Shares
193k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
440k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-10score
Filing-only score

-10

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President, CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Represents performance-based restricted stock units ("PSUs") that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of…

  2. F2

    Each PSU represents a conditional right to receive one share of the Issuer's Common Stock.

  3. F3

    The PSUs vest and settle over two years; 50% vests on August 15, 2027 and 50% vests on July 1, 2028, subject to the continuing service of the Reporting Person on each vesting date.

Original filing · 0001673528-26-000017
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

TRAX